Key result
Primary PCI with DES restores TIMI 3 flow in acute anterior STEMI without complications.
Why the study?
Primary PCI is the preferred reperfusion therapy for acute STEMI due to higher rates of TIMI 3 flow compared to fibrinolysis.
Case Report (n=1)
No
Answers are grounded in this paper and cite their sources.
Demonstrates procedural feasibility in one anterior STEMI case; leaves open safety and efficacy in broader populations.
Coronary reperfusion with primary percutaneous coronary intervention (PPCI) or fibrinolytic therapy improves outcomes in patients with acute ST elevation myocardial infarction (STEMI) or an acute myocardial infarction (AMI) with a new or presumably new left bundle branch block or a true posterior MI. If performed in a timely fashion, PPCI is the reperfusion therapy of choice compared to fibrinolysis because it achieves a higher rate of TIMI 3 flow. Here we describe a case of acute ST elevated anterior myocardial infarction managed with primary percutaneous coronary intervention with the insertion of a drug eluting stent in the Left anterior descending Artery without any procedural complication.University Heart Journal Vol. 10, No. 1, January 2014; 45-46
No takes yet. Share an insight, caveat, or question.
Safiuddin et al. (2015) conducted a case report in Acute ST-segment elevation myocardial infarction (STEMI) (n=1). Primary percutaneous coronary intervention (PCI) with drug-eluting stent (DES) was evaluated. Primary percutaneous coronary intervention with a drug-eluting stent was successfully performed in a 52-year-old man with acute anterior STEMI, resulting in TIMI 3 flow and no procedural complications.
Synapse has enriched 10 related papers. Consider them for comparative context: